Coronavirus Treatment Hopes Fire Up Wall Street

Apr 29, 2020, 10:39 AM | Updated: 10:39 am

(CNN) — US stocks rose sharply Wednesday after Gilead Sciences announced encouraging results for its experimental coronavirus treatment.

The upbeat news on Gilead’s remdesivir is raising hopes of progress on the fight against a pandemic that has killed more than 50,000 people and crushed the American economy.

Gilead Sciences announced it is “aware of positive data” from the National Institute of Allergy and Infectious Diseases’ (NIAID) study of remdesivir for the treatment of COVID-19. The company said it understands the trial “met its primary endpoint” — the main result measured to determine whether a treatment was successful. More information will be released “at an upcoming briefing,” the company added.

The news sent US stocks soaring because there are currently no treatments approved by the FDA for treating coronavirus. The Dow climbed 500 points, or 2%. Gilead rose 4% on Wednesday and is now up 27% year-to-date.

“My confidence went up today. It’s slowly been going up [with each sign] that this drug really works,” said SunTrust analyst Robyn Karnauskas.

Health restrictions imposed to fight the pandemic have caused millions of job losses and led the US economy to contract during the first quarter for the first time since 2014.

No control group

In addition to the positive news on the NIAID study, Gilead announced topline results from its own Phase 3 trial evaluating remdesivir given to hospitalized patients with severe coronavirus. The company said the study demonstrated patients receiving a 10-day treatment course of the drug “achieved similar improvement in clinical status” compared with those taking a five-day treatment. That suggests the shorter regimen could be enough.

Importantly, Gilead said “no new safety signals were identified” in either treatment group. The company plans to submit the full data for publication in the coming weeks.

However, it’s crucial to note that unlike the NIAID study, the Gilead-run trial does not have a control group, where some patients don’t get the drug being tested. That means it will be difficult to say whether the treatment is truly helping, or if patients could have gotten better on their own.

This isn’t the first time remdesivir has set off a big rally on Wall Street. US stocks soared on April 17 on a report about positive signs for the Gilead drug. Yet analysts warned at the time that remdesivir won’t be a silver bullet in the fight against coronavirus.

That’s partially because remidesvir is a potential treatment, not a vaccine that could prevent the disease from infecting people in the first place.

Yet there was positive news on the vaccine front as well. A German company working with Pfizer has begun human trials of a potential coronavirus vaccine that could supply millions by the end of the year.

“Hopefully we’ll get more good news from Gilead and other drug companies on therapeutics that could increase the confidence of people to reengage with businesses again,” Peter Boockvar, chief investment officer at Bleakley Advisory Group, wrote in a note to clients.

Will remdesivir get FDA approval?

The Gilead news was a bit of a surprise, because just last week the company acknowledged it terminated a trial of remdesivir in China early and had no conclusive findings about its effectiveness in treating coronavirus. That development drove global stocks lower.

Former FDA commissioner Scott Gottlieb expressed optimism Wednesday that remdesivir, coupled with other potential treatments as well as ramped up testing, could meaningfully fight America’s fight against coronavirus.

“That could be a robust toolbox that could mitigate the risk and help reduce the fear that if you get this, it’s a race to the bottom and there’s nothing there to help you,” Gottlieb told CNBC.

Gottlieb added on Twitter that remdesivir now appears to “meet or exceed” the standard to get authorization from the FDA for emergency use.

Given the current crisis, Karnauskas, the SunTrust analyst, said the FDA could be more open to approving remdesivir for emergency use even though all data is not yet available.

“I don’t think the normal rules apply during a pandemic,” said Karnauskas. “[But] the FDA has to feel comfortable the drug is safe.”

Drug might not move the needle for Gilead

Even if remdesivir is proven effective against coronvirus, there is no guarantee it will be a big moneymaker for Gilead. That’s partially because there are many unknowns, including how long the pandemic will last, when the drug will get approved and what it will cost — if anything.

“We have no idea about any of these things,” Karnauskas said.

Still, SunTrust ran an analysis assuming remdesivir is the only treatment and is used to treat 250,000 patients a year, costing $10,000 for a 10-day treatment. Even then, SunTrust said Gilead’s fair value will only be $82 a share — or roughly where the stock trades now.

“The stock could overshoot its mark because there is excitement,” Karnauskas said.

KSL 5 TV Live

Top Stories


RSV and flu...
Deidre McPhillips, CNN

Flu season intensifies, holiday gatherings could make it worse

Americans gathered for Thanksgiving last week amid a flu season that's worse than any has been in more than a decade, and experts continue to urge caution as multiple respiratory viruses circulate at high levels nationwide.
2 days ago
Protesters hold up blank papers and chant slogans as they march in protest in Beijing, Sunday, Nov....
Jessie Yeung and CNN's Beijing bureau

Rare protests are spreading across China. Here’s what you need to know

From Shanghai to Beijing, protests have erupted across China in a rare show of dissent against the ruling Communist Party.
2 days ago
Police officers block Shanghai's Urumqi Road on Sunday. (Hector Retamal/AFP/Getty Images)...
CNN's Beijing bureau and Nectar Gan

Protests erupt across China in unprecedented challenge to Xi Jinping’s zero-Covid policy

Protests erupted across China throughout the weekend, including at universities and in Shanghai where hundreds chanted "Step down, Xi Jinping! Step down, Communist Party!"
3 days ago
Salt Lake City Police at the University of Utah Hospital due to a possible bomb threat. (Salt Lake ...
Michael Houck

Police: Unattended bag led to bomb squad response at U of U Hospital

Salt Lake City Police responded to a possible bomb threat at the University of Utah hospital Tuesday afternoon.
15 days ago
Elizabeth Cohen and Naomi Thomas, CNN

COVID-19 medicine for immunocompromised patients is losing effectiveness

Judy Salins considers herself a smart, empowered patient, but until this week, she had no idea that the medicine she takes to defend herself against Covid-19 isn't protecting her as well as it used to.
19 days ago
Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also...
Jamie Gumbrecht, CNN

Paxlovid reduces risk of long Covid, Veterans Affairs study finds

Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a new study by the US Department of Veterans Affairs.
24 days ago

Sponsored Articles

house with for rent sign posted...
Chase Harrington, president and COO of Entrata

Top 5 reasons you may want to consider apartment life over owning a home

There are many benefits of renting that can be overshadowed by the allure of buying a home. Here are five reasons why renting might be right for you.
Festive kitchen in Christmas decorations. Christmas dining room....
Lighting Design

6 Holiday Decor Trends to Try in 2022

We've rounded out the top 6 holiday decor trends for 2022 so you can be ahead of the game before you start shopping. 
Happy diverse college or university students are having fun on their graduation day...
BYU MBA at the Marriott School of Business

How to choose what MBA program is right for you: Take this quiz before you apply!

Wondering what MBA program is right for you? Take this quiz before you apply to see if it will help you meet your goals.
Diverse Group of Energetic Professionals Team Meeting in Modern Office: Brainstorming IT Programmer...
Les Olson

Don’t let a ransomware attack get you down | Protect your workplace today with cyber insurance

Business owners and operators should be on guard to protect their workplace. Cyber insurance can protect you from online attacks.
Hand turning a thermostat knob to increase savings by decreasing energy consumption. Composite imag...
Lighting Design

5 Lighting Tips to Save Energy and Money in Your Home

Advances in lighting technology make it easier to use smart features to cut costs. Read for tips to save energy by using different lighting strategies in your home.
Portrait of smiling practitioner with multi-ethnic senior people...
Summit Vista

How retirement communities help with healthy aging

There are many benefits that retirement communities contribute to healthy aging. Learn more about how it can enhance your life, or the life of your loved ones.
Coronavirus Treatment Hopes Fire Up Wall Street